These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 24215903)
21. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders. La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669 [TBL] [Abstract][Full Text] [Related]
22. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582 [TBL] [Abstract][Full Text] [Related]
23. An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs. Cheatum DE; Arvanitakis C; Gumpel M; Stead H; Geis GS Clin Ther; 1999 Jun; 21(6):992-1003. PubMed ID: 10440623 [TBL] [Abstract][Full Text] [Related]
24. Evidence-based clinical practice guidelines for peptic ulcer disease 2020. Kamada T; Satoh K; Itoh T; Ito M; Iwamoto J; Okimoto T; Kanno T; Sugimoto M; Chiba T; Nomura S; Mieda M; Hiraishi H; Yoshino J; Takagi A; Watanabe S; Koike K J Gastroenterol; 2021 Apr; 56(4):303-322. PubMed ID: 33620586 [TBL] [Abstract][Full Text] [Related]
26. Endoscopic and clinical features of gastric ulcers in Japanese patients with or without Helicobacter pylori infection who were using NSAIDs or low-dose aspirin. Kim Y; Yokoyama S; Watari J; Hori K; Yamasaki T; Okugawa T; Toyoshima F; Kondo T; Sakurai J; Tanaka J; Tomita T; Oshima T; Fukui H; Abe T; Matsumoto T; Miwa H J Gastroenterol; 2012 Aug; 47(8):904-11. PubMed ID: 22350702 [TBL] [Abstract][Full Text] [Related]
27. Prevention of recurrent idiopathic gastroduodenal ulcer bleeding: a double-blind, randomised trial. Wong GLH; Lau LHS; Ching JYL; Tse YK; Ling RHY; Wong VWS; Chiu PWY; Lau JYW; Chan FKL Gut; 2020 Apr; 69(4):652-657. PubMed ID: 31229990 [TBL] [Abstract][Full Text] [Related]
28. Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial. Taha AS; McCloskey C; McSkimming P; McConnachie A Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):469-476. PubMed ID: 29754836 [TBL] [Abstract][Full Text] [Related]
29. Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury. Iijima K; Shimosegawa T World J Gastroenterol; 2015 Jul; 21(25):7709-17. PubMed ID: 26167071 [TBL] [Abstract][Full Text] [Related]
30. Endoscopic survey of low-dose-aspirin-induced gastroduodenal mucosal injuries in patients with ischemic heart disease. Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S234-6. PubMed ID: 19120904 [TBL] [Abstract][Full Text] [Related]
31. Misoprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study. Jiranek GC; Kimmey MB; Saunders DR; Willson RA; Shanahan W; Silverstein FE Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):656-61. PubMed ID: 2491827 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study. Bianchi Porro G; Lazzaroni M; Imbesi V; Montrone F; Santagada T Dig Liver Dis; 2000 Apr; 32(3):201-8. PubMed ID: 10975769 [TBL] [Abstract][Full Text] [Related]
33. Is the new potent acid-inhibitory drug vonoprazan effective for healing idiopathic peptic ulcers? A multicenter observational study in Akita Prefecture, Japan. Sugawara K; Koizumi S; Horikawa Y; Mimori N; Tsuji T; Ishii H; Fujimori S; Onochi K; Watanabe H; Iijima K J Gastroenterol; 2019 Nov; 54(11):963-971. PubMed ID: 31037448 [TBL] [Abstract][Full Text] [Related]
34. Proton pump inhibitor treatment decreases the incidence of upper gastrointestinal disorders in elderly Japanese patients treated with NSAIDs. Sakamoto Y; Shimoyama T; Nakagawa S; Mikami T; Fukuda S Intern Med; 2014; 53(11):1107-11. PubMed ID: 24881732 [TBL] [Abstract][Full Text] [Related]
35. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin. Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510 [TBL] [Abstract][Full Text] [Related]
36. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study. Nagata N; Niikura R; Sekine K; Sakurai T; Shimbo T; Kishida Y; Tanaka S; Aoki T; Okubo H; Watanabe K; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N J Gastroenterol Hepatol; 2015 Feb; 30(2):292-8. PubMed ID: 25339607 [TBL] [Abstract][Full Text] [Related]
37. Omeprazole taken once every other day can effectively prevent aspirin-induced gastrointestinal mucosal damage in rats. Weng J; Song Y; Kuai D; Dai W; Yao Y; Xu W; Li Y; Fan L; Xu B BMC Gastroenterol; 2024 May; 24(1):187. PubMed ID: 38811868 [TBL] [Abstract][Full Text] [Related]
38. Impact of upper gastrointestinal lesions in patients on low-dose aspirin therapy: preliminary study. Kawai T; Watanabe M; Yamashina A J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S23-30. PubMed ID: 20586861 [TBL] [Abstract][Full Text] [Related]
39. Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in Japan. Ishikawa S; Inaba T; Mizuno M; Okada H; Kuwaki K; Kuzume T; Yokota H; Fukuda Y; Takeda K; Nagano H; Wato M; Kawai K Acta Med Okayama; 2008 Feb; 62(1):29-36. PubMed ID: 18323869 [TBL] [Abstract][Full Text] [Related]
40. Who needs prophylaxis of nonsteroidal anti-inflammatory drug-induced ulcers and what is optimal prophylaxis? Goldstein JL Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S11-5. PubMed ID: 10929893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]